Low-dose warfarin functions as an immunomodulator to prevent cyclophosphamide-induced NOD diabetes

Kobe Journal of Medical Sciences

Volumn 54, Issue 1, 2008, Pages 1-13

  Kurohara, Midori ^a   Yasuda, Hisafumi ^a   Moriyama, Hiroaki ^a   Nakayama, Maki ^a   Sakata, Muneaki ^a   Yamada, Katsumi ^a   Kotani, Reiko ^a   Hara, Kenta ^a   Yokono, Koichi ^a   Nagata, Masao ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclophosphamide; Gas6; IL 6; NOD mouse; Type 1 diabetes; Warfarin

Indexed keywords

CYCLOPHOSPHAMIDE; FAS LIGAND; GROWTH ARREST SPECIFIC PROTEIN 6; IMMUNOMODULATING AGENT; INTERLEUKIN 6; MESSENGER RNA; RNA; WARFARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GENE; GENE EXPRESSION; INCIDENCE; INGUINAL LYMPH NODE; INSULITIS; LOW DRUG DOSE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RSE GENE; SIGNAL TRANSDUCTION; SPLEEN CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD95; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED NOD; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; WARFARIN;

EID: 45849124522     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Atkinson, M.A., and N.K. Maclaren. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436
2. Balasa, B., K. Van Gunst, N. Jung, D. Balakrishna, P. Santamaria, T. Hanafusa, N. Itoh, and N. Sarvetnick. 2000. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules. J. Immunol. 165: 2841-2849
3. Boudaly, S., J. Morin, R. Berthier, P. Marche, and C. Boitard. 2002. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Eur. Cytokine. Netw. 13: 29-37
4. Campbell, I.L., A. Cutri, A. Wilson, and L.C. Harrison. 1989. Evidence for IL-6 production by and effects on the pancreatic beta-cell. J. Immunol. 143: 1188-1191
5. Campbell, I.L., T.W. Kay, L. Oxbrow, and L.C. Harrison. 1991. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87: 739-742
6. Eisenbarth, G.S.. 1986. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
7. Feili-Hariri, M., and P.A. Morel. 2001. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin. Immunol. 98: 133-142
8. Graham, D.K., T.L. Dawson, D.L. Mullaney, H.R. Snodgrass, and H.S. Earp. 1994. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell. Growth. Differ. 5: 647-657
9. Grainger, D.J., N.A. McWilliam, T.P. Baglin, and C.D. Byrne. 2001. Suppressing thrombin generation is compatible with the development of atherosclerosis in mice. Thromb. Res. 102: 71-80
10. Harada, M., and S. Makino. 1984. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 27: 604-606
11. Holford, N.H.. 1986. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin. Pharmacokinet. 11: 483-504
12. Kater, A.P., M.P. Peppelenbosch, D.P. Brandjes, and M. Lumbantobing. 2002. Dichotomal effect of the coumadin derivative warfarin on inflammatory signal transduction. Clin. Diagn. Lab. Immunol. 9: 1396-1397
13. Kigasawa, K., K. Saitoh, K. Iwadate, K. Ohkubo, and O. Irino. 1984. A method for monitoring ADP-induced thromboembolism in mice. Thromb. Res. 35: 311-318
14. Lai, C., and G. Lemke. 1991. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron. 6: 691-704
15. Lemke, G., and Q. Lu. 2003. Macrophage regulation by Tyro 3 family receptors. Curr. Opin. Immunol. 15: 31-36
16. Lotz, M., F. Jirik, P. Kabouridis, C. Tsoukas, T. Hirano, T. Kishimoto, and D.A. Carson. 1988. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167: 1253-1258
17. Lu, Q., M. Gore, Q. Zhang, T. Camenisch, S. Boast, F. Casagranda, C. Lai, M.K. Skinner, R. Klein, G.K. Matsushima, H.S. Earp, S.P. Goff, and G. Lemke. 1999. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 398: 723-728
18. Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 293: 306-311
19. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken. Dobutsu. 29: 1-13
20. Manfioletti, G., C. Brancolini, G. Avanzi, and C. Schneider. 1993. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol. 13: 4976-4985
21. Montana, E., S. Bonner-Weir, and G.C. Weir. 1993. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J. Clin. Invest. 91: 780-787
22. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167: 332-344
23. Nagai, K., H. Arai, M. Yanagita, T. Matsubara, H. Kanamori, T. Nakano, N. Iehara, A. Fukatsu, T. Kita, and T. Doi. 2003. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278: 18229-18234
24. Nagata, K., K. Ohashi, T. Nakano, H. Arita, C. Zong, H. Hanafusa, and K. Mizuno. 1996. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J. Biol. Chem. 271: 30022-30027
25. Nakano, T., K. Higashino, N. Kikuchi, J. Kishino, K. Nomura, H. Fujita, O. Ohara, and H. Arita. 1995. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J. Biol. Chem. 270: 5702-5705
26. Nakayama, M., M. Nagata, H. Yasuda, K. Arisawa, R. Kotani, K. Yamada, S.A. Chowdhury, S. Chakrabarty, Z.Z. Jin, H. Yagita, K. Yokono, and M. Kasuga. 2002. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes. Diabetes. 51: 1391-1397
27. Neubauer, A., A. Fiebeler, D.K. Graham, J.P. O'Bryan, C.A. Schmidt, P. Barckow, S. Serke, W. Siegert, H.R. Snodgrass, D. Huhn, and al. et. 1994. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood. 84: 1931-1941
28. O'Bryan, J.P., R.A. Frye, P.C. Cogswell, A. Neubauer, B. Kitch, C. Prokop, R. 3rd Espinosa, M.M. Le Beau, H.S. Earp, and E.T. Liu. 1991. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol. 11: 5016-5031
29. Okada, M., M. Kitahara, S. Kishimoto, T. Matsuda, T. Hirano, and T. Kishimoto. 1988. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J. Immunol. 141: 1543-9
30. Sato, K., Y. Taniuchi, T. Kawasaki, F. Hirayama, H. Koshio, Y. Matsumoto, and Y. Iizumi. 1998. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice. Jpn. J. Pharmacol. 78: 191-197
31. Scott, R.S., E.J. McMahon, S.M. Pop, E.A. Reap, R. Caricchio, P.L. Cohen, H.S. Earp, and G.K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 411: 207-211
32. Serreze, D.V.. 1993. Autoimmune diabetes results from genetic defects manifest by antigen presenting cells. FASEB. J. 7: 1092-1096
33. Steptoe, R.J., J.M. Ritchie, and L.C. Harrison. 2002. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. J. Immunol. 168: 5032-5041
34. Stitt, T.N., G. Conn, M. Gore, C. Lai, J. Bruno, C. Radziejewski, K. Mattsson, J. Fisher, D.R. Gies, P.F. Jones, and al. et. 1995. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell. 80: 661-670
35. Suttie, J.W.. 1985. Vitamin K-dependent carboxylase. Annu. Rev. Biochem. 54: 459-477
36. Varnum, B.C., C. Young, G. Elliott, A. Garcia, T.D. Bartley, Y.W. Fridell, R.W. Hunt, G. Trail, C. Clogston, R.J. Toso, and al. et. 1995. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature. 373: 623-626
37. Vasquez, A.C., M. Feili-Hariri, R.J. Tan, and P.A. Morel. 2004. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clin. Exp. Immunol. 135: 209-218
38. Yanagita, M., K. Ishii, H. Ozaki, H. Arai, T. Nakano, K. Ohashi, K. Mizuno, T. Kita, and T. Doi. 1999. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J. Am. Soc. Nephrol. 10: 2503-2509
39. Yanagita, M., H. Arai, K. Ishii, T. Nakano, K. Ohashi, K. Mizuno, B. Varnum, A. Fukatsu, T. Doi, and T. Kita. 2001. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol. 158: 1423-1432
40. Yanagita, M., H. Arai, T. Nakano, K. Ohashi, K. Mizuno, A. Fukatsu, T. Doi, and T. Kita. 2001. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J. Biol. Chem. 276: 42364-42369
41. Yasunami, R., and J.F. Bach. 1988. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18: 481-484